Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients
Sophie A. Kurk, Petra H.M. Peeters, Rebecca K. Stellato, et al.
Journal of Cachexia Sarcopenia and Muscle (2019) Vol. 10, Iss. 4, pp. 803-813
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Nutrition interventions to treat low muscle mass in cancer
Carla M. Prado, Sarah A. Purcell, Alessandro Laviano
Journal of Cachexia Sarcopenia and Muscle (2020) Vol. 11, Iss. 2, pp. 366-380
Open Access | Times Cited: 300
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment
Anne‐Laure Couderc, Évelyne Liuu, Pascaline Boudou‐Rouquette, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1193-1193
Open Access | Times Cited: 28
Feasibility metrics of exercise interventions during chemotherapy: A systematic review
N. Kearney, Deirdre Connolly, Sanela Begic, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 195, pp. 104272-104272
Open Access | Times Cited: 9
Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?
Jonathan E. Knikman, Hans Gelderblom, Jos H. Beijnen, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 3, pp. 591-604
Open Access | Times Cited: 62
Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis
Alexey Surov, Maciej Pech, Daniel Geßner, et al.
Clinical Nutrition (2021) Vol. 40, Iss. 10, pp. 5298-5310
Closed Access | Times Cited: 47
The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients
Corine de Jong, Najiba Chargi, Gerarda J.M. Herder, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 3, pp. 1554-1564
Open Access | Times Cited: 32
Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving Chemotherapy
Gürkan Güner, Levent Özçakar, Yusuf Baytar, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 1061-1061
Open Access | Times Cited: 7
Body composition and chemotherapy toxicities in breast cancer: a systematic review of the literature
Lori Lewis, Belinda Thompson, Rhiannon Stellmaker, et al.
Journal of Cancer Survivorship (2024)
Open Access | Times Cited: 6
Handgrip weakness, low fat‐free mass, and overall survival in non‐small cell lung cancer treated with curative‐intent radiotherapy
Chris Burtin, Jacques Bezuidenhout, Karin J.C. Sanders, et al.
Journal of Cachexia Sarcopenia and Muscle (2020) Vol. 11, Iss. 2, pp. 424-431
Open Access | Times Cited: 40
Anforderungen an die Infektionsprävention bei der medizinischen Versorgung von immunsupprimierten Patienten

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2021) Vol. 64, Iss. 2, pp. 232-264
Open Access | Times Cited: 33
The myokine Fibcd1 is an endogenous determinant of myofiber size and mitigates cancer-induced myofiber atrophy
Flávia A. Graça, Mamta Rai, Liam C. Hunt, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy
Yizhen Guo, Lai Wei, Sandip H. Patel, et al.
Clinical Lung Cancer (2022) Vol. 23, Iss. 4, pp. 345-355
Open Access | Times Cited: 24
Pretreatment bioelectrical impedance analysis predicts chemotherapy efficacy and toxicity in metastatic colorectal cancer patients
Rikako Kato, Yuji Miyamoto, Yukiharu Hiyoshi, et al.
Clinical Nutrition ESPEN (2025) Vol. 66, pp. 497-504
Closed Access
Preoperative Prediction of Sarcopenia in Patients Scheduled for Gastric and Colorectal Cancer Surgery
Beijia Zhou, Yanjun Song, Chen Chen, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing?
Ioanna Drami, Edward T. Pring, Laura E. Gould, et al.
Clinical Oncology (2021) Vol. 33, Iss. 12, pp. e540-e552
Closed Access | Times Cited: 28
Pancreatic Cancer Prognosis, Malnutrition Risk, and Quality of Life: A Cross-Sectional Study
Kalliopi‐Anna Poulia, Dimitra Antoniadou, Panagiotis Sarantis, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 442-442
Open Access | Times Cited: 21
In vitro co-culture systems of hepatic and intestinal cells for cellular pharmacokinetic and pharmacodynamic studies of capecitabine against colorectal cancer
Chun Ge, Xintong Huang, Sujie Zhang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
The Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity
Αrgyro Papadopetraki, Antonios Giannopoulos, Μaria Maridaki, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5856-5856
Open Access | Times Cited: 12
CT‐determined low skeletal muscle index predicts poor prognosis in patients with colorectal cancer
Yue Feng, Xiaohong Cheng, Mei Xu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 12
Open Access | Times Cited: 4
Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients
Roland Eid, Anthony Tarabay, Pierre Decazes, et al.
Future Oncology (2025), pp. 1-7
Closed Access
Assessing the impact of an intensive dietitian-led telehealth intervention focusing on nutritional adequacy, symptom control and optional supplemental jejunal feeding, on quality of life in patients with pancreatic cancer: a randomised controlled trial protocol
E. J. McShane, Kate Furness, Lauren Hanna, et al.
Nutrition Journal (2025) Vol. 24, Iss. 1
Open Access
The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis
Laura F. J. Huiskamp, Najiba Chargi, Lot A. Devriese, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3780-3780
Open Access | Times Cited: 32
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges
Emanuele Rinninella, Marco Cintoni, Pauline Raoul, et al.
Nutrients (2020) Vol. 12, Iss. 10, pp. 3101-3101
Open Access | Times Cited: 28
Cachexia Index as a Prognostic Indicator in Patients with Gastric Cancer: A Retrospective Study
Can Gong, Qianyi Wan, Rui Zhao, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4400-4400
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top